These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 31242575)

  • 21. Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review.
    Holmar J; de la Puente-Secades S; Floege J; Noels H; Jankowski J; Orth-Alampour S
    Cells; 2020 Nov; 9(11):. PubMed ID: 33172085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology.
    Yaker L; Kamel S; Ausseil J; Boullier A
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33371311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.
    Vanholder R; Nigam SK; Burtey S; Glorieux G
    Toxins (Basel); 2022 Mar; 14(3):. PubMed ID: 35324718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease.
    Addi T; Dou L; Burtey S
    Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30322010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New therapeutic perspectives on protein-bound uremic toxins in chronic kidney disease.
    Malyszko J
    Expert Opin Ther Targets; 2014 Feb; 18(2):109-13. PubMed ID: 24283253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From the gastrointestinal tract (GIT) to the kidneys: live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling.
    Vitetta L; Linnane AW; Gobe GC
    Toxins (Basel); 2013 Nov; 5(11):2042-57. PubMed ID: 24212182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review on uremic toxins: classification, concentration, and interindividual variability.
    Vanholder R; De Smet R; Glorieux G; Argilés A; Baurmeister U; Brunet P; Clark W; Cohen G; De Deyn PP; Deppisch R; Descamps-Latscha B; Henle T; Jörres A; Lemke HD; Massy ZA; Passlick-Deetjen J; Rodriguez M; Stegmayr B; Stenvinkel P; Tetta C; Wanner C; Zidek W;
    Kidney Int; 2003 May; 63(5):1934-43. PubMed ID: 12675874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".
    Castillo-Rodríguez E; Pizarro-Sánchez S; Sanz AB; Ramos AM; Sanchez-Niño MD; Martin-Cleary C; Fernandez-Fernandez B; Ortiz A
    Toxins (Basel); 2017 Mar; 9(4):. PubMed ID: 28333114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uremic toxins and peritoneal dialysis.
    Lameire N; Vanholder R; De Smet R
    Kidney Int Suppl; 2001 Feb; 78():S292-7. PubMed ID: 11169029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adsorption capacity of poly(ether imide) microparticles to uremic toxins.
    Tetali SD; Jankowski V; Luetzow K; Kratz K; Lendlein A; Jankowski J
    Clin Hemorheol Microcirc; 2016; 61(4):657-65. PubMed ID: 26639769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uremic Toxins and Vascular Calcification-Missing the Forest for All the Trees.
    Rapp N; Evenepoel P; Stenvinkel P; Schurgers L
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 33003628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Uremic toxins].
    Vanholder R
    Nephrologie; 2003; 24(7):373-6. PubMed ID: 14650749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harnessing transporters to clear uremic toxins.
    Moe OW
    J Am Soc Nephrol; 2009 Dec; 20(12):2483-4. PubMed ID: 19926890
    [No Abstract]   [Full Text] [Related]  

  • 36. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiorenal syndrome: role of protein-bound uremic toxins.
    Lekawanvijit S; Krum H
    J Ren Nutr; 2015 Mar; 25(2):149-54. PubMed ID: 25556308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on the pharmacokinetics and redox properties of protein-bound uremic toxins.
    Watanabe H; Miyamoto Y; Otagiri M; Maruyama T
    J Pharm Sci; 2011 Sep; 100(9):3682-95. PubMed ID: 21538353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.
    Mutsaers HA; Engelke UF; Wilmer MJ; Wetzels JF; Wevers RA; van den Heuvel LP; Hoenderop JG; Masereeuw R
    PLoS One; 2013; 8(8):e71199. PubMed ID: 23936492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.
    Florens N; Calzada C; Lyasko E; Juillard L; Soulage CO
    Toxins (Basel); 2016 Dec; 8(12):. PubMed ID: 27999257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.